Register for free to listen to this article
Listen with Speechify
0:00
2:00
LOS ANGELES—Researchers from UCLA and Northwestern University are using nanotechnology to develop a new way to deliver drugs that is invisible to the immune system. With nanoscale polymer films—about four nanometers per layer—the research team built a platform of sorts to hold and slowly release an anti-inflammatory drug, a significant drug delivery hurdle that could lead to new and better therapeutic delivery methods for cancer and other diseases.
 
The study provides an example of the enormous potential and clinical significance that nanomaterials may represent in such fields as oncology, endocrinology and cardiology.

"One of the key advantages with the nanocloak polymer/nanofilm devices that we are developing is that it is a platform system that can be integrated with virtually any drug (chemically synthesized, protein/antibody-based, etc.)," says Dean Ho, an assistant professor of biomedical and mechanical engineering with the McCormick School of Engineering and Applied Science, a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the study's senior author.

The researchers used nanoscale polymer films, about four nanometers per layer, to build a sort of matrix or platform to hold and slowly release an anti-inflammatory drug. The films are orders of magnitude thinner than conventional drug delivery coatings, says Genhong Cheng, a researcher at UCLA's Jonsson Comprehensive Cancer Center and one of the study's authors.

"Using this system, drugs could be released slowly and under control for weeks or longer," says Cheng, a professor of microbiology and molecular genetics.

Researchers coated tiny chips with layers of the nanoscale polymer films, which are inert and helped provide a Harry Potter-like invisibility cloak for the chips, hiding them from the body's natural defenses. They then added Dexamethasone, an anti-inflammatory drug, between the layers. The chips were implanted in mice, and researchers found that the Dexamethasone-coated films suppressed the expression of cytokines, proteins released by the cells of the immune system to initiate a response to a foreign invader. Mice without implants and those with uncoated implants were studied to compare immune response.

The uncoated implants generated an inflammatory response from the surrounding tissue, which ultimately would have led to the body's rejection of the implant and the breakdown of its functionality. However, tissue from the mice without implants and the mice with the nano-cloaked implants were virtually identical, proving that the film-coated implants were effectively shielded from the body's defense system, says Edward Chow, a former UCLA graduate student who participated in the study and is one of its authors.

"The next step of the project will involve using the nanocloaking polymer as the foundation for an implantable nanofilm device for localized cancer treatment," says Ho, adding that within the next year or so, the technology could see rapid movement towards its next phase of development.

The technology also may prove to be an effective approach for delivering multiple drugs, controlling the sequence of multi-drug delivery.

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue